ICD-10 category · Chapter XX · Y40-Y59

Y56 Adverse effects in therapeutic use, topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs

11 codes under Y56 in the South African Master Industry Table 2021, 10 valid for clinical use.

Valid: the code is at its most specific level and may go on an account. Heading only: code to a more specific entry beneath it. PMB and CDL: a Prescribed Minimum Benefit or Chronic Disease List condition per the Council for Medical Schemes. † dagger and * asterisk codes are used as a pair. How to read the table
Code	Description	Use	Benefits
Y56	Adverse effects in therapeutic use, topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	Heading only	—
Y56.0	Adverse effects in therapeutic use, local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	Valid · not as primary	—
Y56.1	Adverse effects in therapeutic use, antipruritics	Valid · not as primary	—
Y56.2	Adverse effects in therapeutic use, local astringents and local detergents	Valid · not as primary	—
Y56.3	Adverse effects in therapeutic use, emollients, demulcents and protectants	Valid · not as primary	—
Y56.4	Adverse effects in therapeutic use, keratolytics, keratoplastics and other hair treatment drugs and preparations	Valid · not as primary	—
Y56.5	Adverse effects in therapeutic use, ophthalmological drugs and preparations	Valid · not as primary	—
Y56.6	Adverse effects in therapeutic use, otorhinolaryngological drugs and preparations	Valid · not as primary	—
Y56.7	Adverse effects in therapeutic use, dental drugs, topically applied	Valid · not as primary	—
Y56.8	Adverse effects in therapeutic use, other topical agents	Valid · not as primary	—
Y56.9	Adverse effects in therapeutic use, topical agent, unspecified	Valid · not as primary	—

Source and terms

Reproduced from the national table, unaltered.

The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page

Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.

ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.

Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.

Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.

This lookup is a reference to the published code table, not coding advice. Code assignment is the treating practitioner’s responsibility, following the South African ICD-10 Coding Standards and Guidelines and the WHO ICD-10 volumes. GreenNotes does not warrant that the table is complete or current.

This is the South African table. Most ICD-10 results online are the United States’ ICD-10-CM, a different code set that South African medical schemes do not accept. Regulation 5 of the General Regulations under the Medical Schemes Act requires the diagnostic code on every account, and the Master Industry Table is the list it is coded from.

In GreenNotes

Code the consultation once. The invoice and the claim pick it up.

GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.

Start a 14-day Clinical trial See notes become claims